Authors:
de Witte, H
van den Hurk, M
Sweep, F
Benraad, T
Geurts-Moespot, A
Ruiter, D
Verhofstad, A
Citation: H. De Witte et al., Development of quality control preparations for immunocytochemical assessment of urokinase-type plasminogen activator, APPL IMMUNO, 9(3), 2001, pp. 281-287
Authors:
Vesce, F
Scapoli, C
Giovannini, G
Piffanelli, A
Geurts-Moespot, A
Sweep, FCGJ
Citation: F. Vesce et al., Plasminogen activator system in serum and amniotic fluid of euploid and aneuploid pregnancies, OBSTET GYN, 97(3), 2001, pp. 404-408
Authors:
Foekens, JA
Peters, HA
Grebenchtchikov, N
Look, MP
Meijer-van Gelder, ME
Geurts-Moespot, A
van der Kwast, TH
Sweep, CGJ
Klijn, JGM
Citation: Ja. Foekens et al., High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer, CANCER RES, 61(14), 2001, pp. 5407-5414
Authors:
de Witte, JH
Foekens, JA
Brunner, N
Heuvel, JJTM
van Tienoven, TH
Look, MP
Klijn, JGM
Geurts-Moespot, A
Grebenchtchikov, N
Benraad, TJ
Sweep, CGJ
Citation: Jh. De Witte et al., Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours, BR J CANC, 85(1), 2001, pp. 85-92
Authors:
Span, P
Heuvel, J
Romain, S
Piffanelli, A
Martin, PM
Geurts-Moespot, A
Sweep, F
Citation: P. Span et al., EORTC receptor and biomarker study group report analytical and technical evaluation of a thymidine kinase radio-enzymatic assay in breast cancer cytosols, ANTICANC R, 20(2A), 2000, pp. 681-687
Authors:
Westphal, JR
Van't Hullenaar, R
Geurts-Moespot, A
Sweep, FCJG
Verheijen, JH
Bussemakers, MMG
Askaa, J
Clemmensen, I
Eggermont, AAM
Ruiter, DJ
De Waal, RMW
Citation: Jr. Westphal et al., Angiostatin generation by human tumor cell lines: Involvement of plasminogen activators, INT J CANC, 86(6), 2000, pp. 760-767